STRONGBRIDGE BIOPHARMA plc Proceeds from Issuance Initial Public Offering
STRONGBRIDGE BIOPHARMA plc reported Proceeds from Issuance Initial Public Offering of $19.50 million for the 3-month period ending 2016-03-31, per its 6-K filed 2016-05-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-04-04
- STRONGBRIDGE BIOPHARMA plc proceeds from issuance initial public offering for the quarter ending 2016-03-31 was $19.50M.
- STRONGBRIDGE BIOPHARMA plc proceeds from issuance initial public offering for the quarter ending 2015-12-31 was $19.50M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|
| 2016-03-31 | $19.50M 6-K · filed 2016-05-17 | $39.00M derived: sum of 2 quarters · filed 2016-12-30 | |
| 2015-12-31 | $19.50M 6-K · filed 2016-12-30 | $19.48M 20-F · filed 2017-04-04 |